Multiplex Assay Market Overview
The multiplex assay is a process in which many analytes such as proteins, biomolecules, chemokines, cytolines, and others are outlined by noticing and measuring them. This assay is used to increase different targets in a polymerase chain reaction (PCR) and gather the bulk of information from small amounts of proteins or other analytes in less time as compared to conventional methods such as ELISA. In addition, multiplex assays are extensively used for RNA detection, linkage analysis, pathogen identification, mutation analysis, and others.
The Multiplex Assay Market is observing noteworthy growth, due to increasing R & D activities for the pharmaceutical sector for the treatment of many diseases. The Multiplex Assay is used for quick and easier analysis of diseases and they are automated, hence fueling the multiplex assay market growth. few other key aspects positively affecting the growth of the multiplex assay market are the rising incidence of infectious diseases and cancer that can be easily observed at earlier stages, government and private funding for research and innovation activities. Besides, strategic acquisitions of companies to enhance the reach of the multiplex assay kits further boost the growth of the market.
Progress in the highly dense nanoarray technology has made the drug screening process fast and time-effective. Rising awareness of people for various diseases, cancer and Alzheimer’s disease, etc. created a requirement for cost-effective and time-saving measurement of multiple analytes in a single sample. These are some reasons facilitating the global multiplex assay market development.
On the other hand, factors such as lack of skilled laborers and high capital investment are hampering the market growth.
Multiplex Assay Market Segment Overview
The flow cytometry segment has hold a remarkable share in the market in 2017. This is due to the ease of performing multiplex assays through technology, which offers the flexibility of running a large number of samples simultaneously with accuracy. The consumables segment is anticipated to show good growth during the forecast period owing to the huge increase in research and development by major market players. Expansion of the protein segment can be done due to an increase in analyzing protein samples exactly and simultaneously for dynamic and static, predictive, and biological research.
The increasing focus on the establishment of biotechnology companies in emerging economies. Furthermore, an increase in the number of biotechnology companies, globally, mainly in Europe and Asia, is expected to boost the growth in the market
Because of the Covid-19 pandemic, top market players speed up their operations for testing and tracking the infection of COVID-19. This has given a chance for accelerating growth for companies operating in the Multiplex Assays market
Multiplex Assay Regional Overview
North America is expected to hold its dominance in terms of market share over the forecast period. This is due to the bigger adoption of the multiplex assay. The major reasons contributing to growth in market development are the increase in technological advancement, the presence of advanced healthcare infrastructures as well as increased occurrence of various chronic disorders, etc. Asia Pacific region is expected to show remarkable growth in coming years owing to increased adoption of advanced technology, rising demand for safe and effective treatment options, and the launching of new products.
Multiplex Assay Market Competitor overview
Multiplex Assay market, which is highly competitive, involves various market players. A few of major market players are Luminex Corporation, Thermo Fisher Scientific, Inc., Seegene, Inc., Meso Scale Diagnostics, LLC., Abcam plc, Bio-Rad Laboratories, Inc., QIAGEN N.V., Merck KGaA, Quansys Biosciences, and Illumina, Inc.
- In April 2020, Bio-Rad Laboratories Inc., one of the major players in the global multiplex assay market, declared that it has received the Emergency Use Authorization by the U.S FDA for its Droplet Digital PCR (ddPCR) SARS-CoV-2 Test Kit that runs on Bio-Rad's QX200 and QXDx ddPCR systems. Owing to the good sensitivity of this test it is well for screening upper respiratory track samples in patients in the early stage of infection, or patients recovering from the infection.
- Also, in the same month, Bio-Rad Laboratories, Inc., announced the launch of ‘Serology Assay,’ a blood-based immunoassay kit, formulated to identify antibodies to the virus associated with the COVID-19 pandemic, the SARS-CoV-2. Of the 700 samples detected by this test, 99% success results have been achieved.
- Furthermore, in March 2020, Thermo Fisher Scientific, announced the launch of its five new Thermo Scientific SureTect PCR Assay test kits, along with updated software to test food and related samples. These test kits are used for examining the existence of Cronobacter species, Listeria species, Listeria monocytogenes, Salmonella Enteritidis, and Salmonella Typhimurium, in food products and consumables.
Multiplex Assay Market, Key Players
- Luminex Corporation
- Thermo Fisher Scientific, Inc.
- Seegene, Inc.,
- Meso Scale Diagnostics, LLC.
- Abcam plc
- Bio-Rad Laboratories, Inc.
- QIAGEN N.V.
- Merck KGaA
- Quansys Biosciences
- Illumina, Inc.
- Becton
- Dickinson and Company
- Abcam PLC, Seegene Inc.
Multiplex Assay Market Segmentation
Multiplex Assay Market, By Type
- Protein
- Planar
- Bead-Based
- Nucleic Acid
- Cell
Multiplex Assay Market, By Product
- Instruments
- Consumables
- Reagents and Kits
- Microplates and Micropipettes
- Others
- Software
Multiplex Assay Market, By Technology
- Multiplex RT-PCR
- Flow Cytometry
- Fluorescence
- Luminescence
- Others
Multiplex Assay Market, By Application
- Research & Development
- Drug Discovery & Development
- Biomarker Research & Application
- Diagnosis
- Infectious Diseases
- Autoimmune Diseases
- Cancer
- Cardiovascular Diseases
- Neuro-Endocrine Diseases
- Others
- Others
Multiplex Assay Market, By End-user
- Academic and Research Centers
- Biotechnology and Biopharmaceutical Companies
- Diagnostic Centers
- Hospitals
- Others
Multiplex Assay market, By Region:
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Multiplex Assay Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Type
- 5.2.1. Protein
- 5.2.1.1. Planar
- 5.2.1.2. Bead-Based
- 5.2.2. Nucleic Acid
- 5.2.3. Cell
- 5.2.1. Protein
- 5.3. Market Analysis, Insights and Forecast – By Product
- 5.3.1. Instruments
- 5.3.2. Consumables
- 5.3.2.1. Reagents and Kits
- 5.3.2.2. Microplates and Micropipettes
- 5.3.2.3. Others
- 5.3.3. Software
- 5.4. Market Analysis, Insights and Forecast – By Technology
- 5.4.1. Multiplex RT-PCR
- 5.4.2. Flow Cytometry
- 5.4.3. Fluorescence
- 5.4.4. Luminescence
- 5.4.5. Others
- 5.5. Market Analysis, Insights and Forecast – By Application
- 5.5.1. Research & Development
- 5.5.1.1. Drug Discovery & Development
- 5.5.1.2. Biomarker Research & Application
- 5.5.2. Diagnosis
- 5.5.2.1. Infectious Diseases
- 5.5.2.2. Autoimmune Diseases
- 5.5.2.3. Cancer
- 5.5.2.4. Cardiovascular Diseases
- 5.5.2.5. Neuro-Endocrine Diseases
- 5.5.2.6. Others
- 5.5.3. Others
- 5.5.1. Research & Development
- 5.6. Market Analysis, Insights and Forecast – By End-user
- 5.6.1. Academic and Research Centers
- 5.6.2. Biotechnology and Biopharmaceutical Companies
- 5.6.3. Diagnostic Centers
- 5.6.4. Hospitals
- 5.6.5. Others
- 5.7. Market Analysis, Insights and Forecast – By Region
- 5.7.1. North America
- 5.7.2. Latin America
- 5.7.3. Europe
- 5.7.4. Asia Pacific
- 5.7.5. Middle East and Africa
6. North America Multiplex Assay Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Type
- 6.2.1. Protein
- 6.2.1.1. Planar
- 6.2.1.2. Bead-Based
- 6.2.2. Nucleic Acid
- 6.2.3. Cell
- 6.2.1. Protein
- 6.3. Market Analysis, Insights and Forecast – By Product
- 6.3.1. Instruments
- 6.3.2. Consumables
- 6.3.2.1. Reagents and Kits
- 6.3.2.2. Microplates and Micropipettes
- 6.3.2.3. Others
- 6.3.3. Software
- 6.4. Market Analysis, Insights and Forecast – By Technology
- 6.4.1. Multiplex RT-PCR
- 6.4.2. Flow Cytometry
- 6.4.3. Fluorescence
- 6.4.4. Luminescence
- 6.4.5. Others
- 6.5. Market Analysis, Insights and Forecast – By Application
- 6.5.1. Research & Development
- 6.5.1.1. Drug Discovery & Development
- 6.5.1.2. Biomarker Research & Application
- 6.5.2. Diagnosis
- 6.5.2.1. Infectious Diseases
- 6.5.2.2. Autoimmune Diseases
- 6.5.2.3. Cancer
- 6.5.2.4. Cardiovascular Diseases
- 6.5.2.5. Neuro-Endocrine Diseases
- 6.5.2.6. Others
- 6.5.3. Others
- 6.5.1. Research & Development
- 6.6. Market Analysis, Insights and Forecast – By End-user
- 6.6.1. Academic and Research Centers
- 6.6.2. Biotechnology and Biopharmaceutical Companies
- 6.6.3. Diagnostic Centers
- 6.6.4. Hospitals
- 6.6.5. Others
- 6.7. Market Analysis, Insights and Forecast – By Country
- 6.7.1. U.S.
- 6.7.2. Canada
7. Latin America Multiplex Assay Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Type
- 7.2.1. Protein
- 7.2.1.1. Planar
- 7.2.1.2. Bead-Based
- 7.2.2. Nucleic Acid
- 7.2.3. Cell
- 7.2.1. Protein
- 7.3. Market Analysis, Insights and Forecast – By Product
- 7.3.1. Instruments
- 7.3.2. Consumables
- 7.3.2.1. Reagents and Kits
- 7.3.2.2. Microplates and Micropipettes
- 7.3.2.3. Others
- 7.3.3. Software
- 7.4. Market Analysis, Insights and Forecast – By Technology
- 7.4.1. Multiplex RT-PCR
- 7.4.2. Flow Cytometry
- 7.4.3. Fluorescence
- 7.4.4. Luminescence
- 7.4.5. Others
- 7.5. Market Analysis, Insights and Forecast – By Application
- 7.5.1. Research & Development
- 7.5.1.1. Drug Discovery & Development
- 7.5.1.2. Biomarker Research & Application
- 7.5.2. Diagnosis
- 7.5.2.1. Infectious Diseases
- 7.5.2.2. Autoimmune Diseases
- 7.5.2.3. Cancer
- 7.5.2.4. Cardiovascular Diseases
- 7.5.2.5. Neuro-Endocrine Diseases
- 7.5.2.6. Others
- 7.5.3. Others
- 7.5.1. Research & Development
- 7.6. Market Analysis, Insights and Forecast – By End-user
- 7.6.1. Academic and Research Centers
- 7.6.2. Biotechnology and Biopharmaceutical Companies
- 7.6.3. Diagnostic Centers
- 7.6.4. Hospitals
- 7.6.5. Others
- 7.7. Insights and Forecast – By Country
- 7.7.1. Brazil
- 7.7.2. Mexico
- 7.7.3. Rest of Latin America
8. Europe Multiplex Assay Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Type
- 8.2.1. Protein
- 8.2.1.1. Planar
- 8.2.1.2. Bead-Based
- 8.2.2. Nucleic Acid
- 8.2.3. Cell
- 8.2.1. Protein
- 8.3. Market Analysis, Insights and Forecast – By Product
- 8.3.1. Instruments
- 8.3.2. Consumables
- 8.3.2.1. Reagents and Kits
- 8.3.2.2. Microplates and Micropipettes
- 8.3.2.3. Others
- 8.3.3. Software
- 8.4. Market Analysis, Insights and Forecast – By Technology
- 8.4.1. Multiplex RT-PCR
- 8.4.2. Flow Cytometry
- 8.4.3. Fluorescence
- 8.4.4. Luminescence
- 8.4.5. Others
- 8.5. Market Analysis, Insights and Forecast – By Application
- 8.5.1. Research & Development
- 8.5.1.1. Drug Discovery & Development
- 8.5.1.2. Biomarker Research & Application
- 8.5.2. Diagnosis
- 8.5.2.1. Infectious Diseases
- 8.5.2.2. Autoimmune Diseases
- 8.5.2.3. Cancer
- 8.5.2.4. Cardiovascular Diseases
- 8.5.2.5. Neuro-Endocrine Diseases
- 8.5.2.6. Others
- 8.5.3. Others
- 8.5.1. Research & Development
- 8.6. Market Analysis, Insights and Forecast – By End-user
- 8.6.1. Academic and Research Centers
- 8.6.2. Biotechnology and Biopharmaceutical Companies
- 8.6.3. Diagnostic Centers
- 8.6.4. Hospitals
- 8.6.5. Others
- 8.7. Market Analysis, Insights and Forecast – By Country
- 8.7.1. UK
- 8.7.2. Germany
- 8.7.3. France
- 8.7.4. Italy
- 8.7.5. Spain
- 8.7.6. Russia
- 8.7.7. Rest of Europe
9. Asia Pacific Multiplex Assay Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Type
- 9.2.1. Protein
- 9.2.1.1. Planar
- 9.2.1.2. Bead-Based
- 9.2.2. Nucleic Acid
- 9.2.3. Cell
- 9.2.1. Protein
- 9.3. Market Analysis, Insights and Forecast – By Product
- 9.3.1. Instruments
- 9.3.2. Consumables
- 9.3.2.1. Reagents and Kits
- 9.3.2.2. Microplates and Micropipettes
- 9.3.2.3. Others
- 9.3.3. Software
- 9.4. Market Analysis, Insights and Forecast – By Technology
- 9.4.1. Multiplex RT-PCR
- 9.4.2. Flow Cytometry
- 9.4.3. Fluorescence
- 9.4.4. Luminescence
- 9.4.5. Others
- 9.5. Market Analysis, Insights and Forecast – By Application
- 9.5.1. Research & Development
- 9.5.1.1. Drug Discovery & Development
- 9.5.1.2. Biomarker Research & Application
- 9.5.2. Diagnosis
- 9.5.2.1. Infectious Diseases
- 9.5.2.2. Autoimmune Diseases
- 9.5.2.3. Cancer
- 9.5.2.4. Cardiovascular Diseases
- 9.5.2.5. Neuro-Endocrine Diseases
- 9.5.2.6. Others
- 9.5.3. Others
- 9.5.1. Research & Development
- 9.6. Market Analysis, Insights and Forecast – By End-user
- 9.6.1. Academic and Research Centers
- 9.6.2. Biotechnology and Biopharmaceutical Companies
- 9.6.3. Diagnostic Centers
- 9.6.4. Hospitals
- 9.6.5. Others
- 9.7. Market Analysis, Insights and Forecast – By Country
- 9.7.1. China
- 9.7.2. India
- 9.7.3. Japan
- 9.7.4. Australia
- 9.7.5. South East Asia
- 9.7.6. Rest of Asia Pacific
10. Middle East & Africa Multiplex Assay Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Type
- 10.2.1. Protein
- 10.2.1.1. Planar
- 10.2.1.2. Bead-Based
- 10.2.2. Nucleic Acid
- 10.2.3. Cell
- 10.2.1. Protein
- 10.3. Market Analysis, Insights and Forecast – By Product
- 10.3.1. Instruments
- 10.3.2. Consumables
- 10.3.2.1. Reagents and Kits
- 10.3.2.2. Microplates and Micropipettes
- 10.3.2.3. Others
- 10.3.3. Software
- 10.4. Market Analysis, Insights and Forecast – By Technology
- 10.4.1. Multiplex RT-PCR
- 10.4.2. Flow Cytometry
- 10.4.3. Fluorescence
- 10.4.4. Luminescence
- 10.4.5. Others
- 10.5. Market Analysis, Insights and Forecast – By Application
- 10.5.1. Research & Development
- 10.5.1.1. Drug Discovery & Development
- 10.5.1.2. Biomarker Research & Application
- 10.5.2. Diagnosis
- 10.5.2.1. Infectious Diseases
- 10.5.2.2. Autoimmune Diseases
- 10.5.2.3. Cancer
- 10.5.2.4. Cardiovascular Diseases
- 10.5.2.5. Neuro-Endocrine Diseases
- 10.5.2.6. Others
- 10.5.3. Others
- 10.5.1. Research & Development
- 10.6. Market Analysis, Insights and Forecast – By End-user
- 10.6.1. Academic and Research Centers
- 10.6.2. Biotechnology and Biopharmaceutical Companies
- 10.6.3. Diagnostic Centers
- 10.6.4. Hospitals
- 10.6.5. Others
- 10.7. Market Analysis, Insights and Forecast – By Country
- 10.7.1. GCC
- 10.7.2. South Africa
- 10.7.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Company Market Share Analysis, 2018
- 11.2. Key Industry Developments
- 11.3. Company Profile
- 11.4. Luminex Corporation
- 11.4.1. Business Overview
- 11.4.2. Segment 1 & Service Offering
- 11.4.3. Overall Revenue
- 11.4.4. Geographic Presence
- 11.4.5. Recent Development
- 11.5. Thermo Fisher Scientific, Inc.
- 11.6. Seegene, Inc.,
- 11.7. Meso Scale Diagnostics, LLC.
- 11.8. Abcam plc
- 11.9. Bio-Rad Laboratories, Inc.
- 11.10. QIAGEN N.V.
- 11.11. Merck KGaA
- 11.12. Quansys Biosciences
- 11.13. Illumina, Inc.
- 11.14. Becton
- 11.15. Dickinson and Company
- 11.16. Abcam PLC, Seegene Inc.
- 11.17. Creative Group, Inc.
- 11.18. the Interpublic Group of Companies, Inc.
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
